drugset / Trial / NCT00489840
Treatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave Acetate
Phase 1/2
Completed
5 enrolled
Manhattan Eye, Ear & Throat Hospital
Alcon Research · collabLuEsther T. Mertz Retinal Research Center · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Investigation to evaluate Anecortave Acetate in the treatment of chronic central serous chorioretinopathy
Timeline
- Start
- 2007-05
- Primary completion
- 2010-07
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anecortave Acetate | Unknown | 15 mg | Other |